DanieleRP, EliasJA, EpsteinPE, RossmanMD. Bronchoalveolar lavage: role in pathogenesis, diagnosis, and management of interstitial lung diseases. Ann Intern Med1985;102(1):93–108.
2.
CrystalRG, ReynoldsHY, KalicaAR. Bronchoalveolar lavage. The report of an international conference. Chest1986;90(1):122–131.
3.
ReynoldsHY, NewballHH. Fluid and cellular milieu of the human respiratory tract, Immunologic and infectious reactions in the lung. Volume I. KirkpatrickCH, ReynoldsHY, editors. New York: New York and Basel, Marcel Decker; 1976:3–27.
4.
DebeljakA, MermoljaM, SorliJ, ZupancicM, ZormanM, Rem-skarJ.Bronchoalveolar lavage in the diagnosis of peripheral primary and secondary malignant lung tumors. Respiration1994;61(4):226–230.
RennardSI, ThompsonAB, FloreaniAA. Bronchoalveolar lavage in the study of asthma [editorial]. Chest1992;102(1):1–2.
8.
FeinA, Wiener-KronishJP, NiedermanM, MatthayMA. Pathophysiology of the adult respiratory distress syndrome. What have we learned from human studies?Crit Care Clin1986;2(3):429–453.
9.
IdellS, CohenAB. Bronchoalveolar lavage in patients with the adult respiratory distress syndrome. Clin Chest Med1985;6(3):459–471.
10.
WhiteDA. Pulmonary infection in the immunocompromised patient. Semin Thorac Cardiovasc Surg1995;7(2):78–87.
11.
ChastreJ, FagonJY, SolerP, BornetM, DomartY, TrouilletJL, et al. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med1988;85(4):499–506.
12.
StoverDE, WhiteDA, RomanoPA, GelleneRA. Diagnosis of pulmonary disease in acquired immune deficiency syndrome (AIDS). Role of bronchoscopy and bronchoalveolar lavage. Am Rev Respir Dis1984;130(4):659–662.
CrystalRG, GadekJE, FerransVJ, FulmerJD, LineBR, HunninghakeGW. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med1981;70(3):542–568.
15.
GreeningAP. Bronchoalveolar lavage [editorial]. Br Med J Clin Res Ed1982;284(6333):1896–1897.
16.
American Thoracic Society. Medical Section of the American Lung Association. Guidelines for fiberoptic bronchoscopy in adults. Am Rev Respir Dis1987;136:1066.
17.
American Association for Respiratory Care. Clinical practice guideline: fiberoptic bronchoscopy assisting. Respir Care1993;38(11):1173–1178.
18.
LowRB, DavidGS, GiancolaMS. Biochemical analysis of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmoker. Am Rev Respir Dis1978;118:863–875.
19.
FurthRV. Origin and kinetics of monocytes and macrophages. Semin Hematology1970;7:125–141.
20.
MerchantRK, SchwartzDA, HelmersRA, DaytonCS, HunninghakeGW. Bronchoalveolar lavage cellularity. The distribution in normal volunteers. Am Rev Respir Dis1992;146(2):446–453.
21.
ReynoldsHY. Bronchoalveolar lavage. Am Rev Respir Dis1987;135 (1):250–263.
22.
MidullaF, VillaniA, MerollaR, BjermerL, SandstromT, RonchettiR.Bronchoalveolar lavage studies in children without parenchymal lung disease: cellular constituents and protein levels. Pediatr Pulmonol1995;20(2):112–118.
23.
RiedlerJ, GriggJ, StoneC, TauroG, RobertsonCF. Bronchoalveolar lavage cellularity in healthy children. Am J Respir Crit Care Med1995;152(1):163–168.
24.
CohenAB, GoldWM. Defense mechanisms of the lungs. Annu Rev Physiol1975;37:325–350.
25.
GadekJE, HunninghakeGW, ZimmermanR, KelmanJ, FulmerJ, CrystalRG. Pathogenetic studies in idiopathic pulmonary fibrosis. Control of neutrophil migration by immune complexes. Chest1979;75(Suppl):264S–265S.
26.
GoldeDW, FinleyTN, ClineMJ. Production of colony-stimulating factor by human macrophages. Lancet1972;2(792):1397–1399.
27.
CohenAB. Interrelationships between the human alveolar macrophage and alpha-1-antitrypsin. J Clin Invest1973;52(11):2793–2799.
ReynoldsHY, ChrétienJ.Respiratory tract fluids: analysis of content and contemporary use in understanding lung diseases. Dis Mon1984;30(5):1–103.
30.
HunninghakeGW, GadekJE, KawanamiO, FerransVJ, CrystalRG. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol1979;97 (1):149–206.
31.
BellDY, HasemanJA, SpockA, McLennanG, HookGE. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. Am Rev Respir Dis1981;124(1):72–79.
32.
ShasbyDM, ShasbySS. Active transendothelial transport of albumin: interstitium to lumen. Circ Res1985;57(6):903–908.
33.
WarrGA, MartinRR, SharpPM, RossenRD. Normal human bronchial immunoglobulins and proteins: effects of cigarette smoking. Am Rev Respir Dis1977;116(1):25–30.
34.
RennardSI, BassetSI, LecossierD, O'DonnellKM, MartinPG, PinkstonP, CrystalRG. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol1986;60(2):532–538.
35.
FalkGA, OkinakaAJ, SiskindGW. Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary diseaseAm Rev Respir Dis1972;105(1):14–21.
36.
ReynoldsHY, FulmerJD, KazmierowskiJA, RobertsWC, FrankMM, CrystalRG. Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest1977;59(1):165–175.
37.
ReynoldsHY, NewballHH. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med1974;84(4):559–573.
38.
DenisM, BedardM, LavioletteM, CormierY.A study of monokine release and natural killer activity in the bronchoalveolar lavage of subjects with farmer's lung. Am Rev Respir Dis1993;147(4):934–939.
39.
PinkstonP, BittermanPB, CrystalRG. Spontaneous release of interleukin-2 by lung T-lymphocytes in active pulmonary sarcoidosis. N Engl J Med1983;308(14):793–800.
40.
HinmanLM, StevensCA, MatthayRA, GeeJB. Angiotensin convertase activities in human alveolar macrophages: effects of cigarette smoking and sarcoidosis. Science1979;205(4402):202–203.
41.
JanoffA, RajuL, DearingR.Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and nonsmokers. Am Rev Respir Dis1983;127(5):540–544.
42.
KorenHS, DevlinRB, GrahamDE, MannR, McGeeMP, HorstmanDH, et al. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis1989;139(2):407–415.
43.
MarchandiseFX, MathieuB, FrancisC, SibilleY.Local increase of antiprotease and neutrophil elastase-alpha 1-proteinase inhibitor complexes in lung cancer. Eur Respir J1989;2(7):623–629.
44.
SchmekelB, HornbladY, LindenM, SundstromC, VengeP.Myeloperoxidase in human lung lavage. II. Internalization of myeloperoxidase by alveolar macrophages. Inflammation1990;14(4):455–461.
45.
WaltiH, TordetC, GerbautL, SaugierP, MorietteG, RelierJP. Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections. Pediatr Res1989;26(4):351–355.
46.
OlsenGN, HarrisJO, CastleJR, WaldmanRH, KarmgardHJ. Alpha-1-antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects. J Clin Invest1975;55(2):427–430.
47.
SepperR, KonttinenYT, DingY, TakagiM, SorsaT.Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest1995;107(6):1641–1647.
48.
BellDY, SpockA, HookGER. Plasma proteins of the bronchoalveolar lining from human lung. FASEB1979;38:522.
49.
RiiseGC, AhlstedtS, LarssonS, EnanderI, JonesI, LarssonP, AndersonB.Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax1995;50(4):360–365.
50.
KobayashiJ, KitamuraS.KL-6: a serum marker for interstitial pneumonia. Chest1995;108(2):311–315.
51.
GoldsteinN, LippmannML, GoldbergSK, FeinAM, ShapiroB, LeonSA. Usefulness of tumor markers in serum and bronchoalveolar lavage of patients undergoing fiberoptic bronchoscopy. Am Rev Respir Dis1985;132(1):60–64.
52.
MerrillWW, GoodmanM, MatthayRA, NaegelGP, VandevoordeJP, MylAD, ReynoldsHY. Quantitation of carcinoembryonic antigen in the lung lining fluid of normal smokers and nonsmokers. Am Rev Respir Dis1981;123(1):29–31.
53.
PerezT, FarreJM, GossetP, WallaertB, DuquesnoyB, VoisinC, et al. Subclinical alveolar inflammation in rheumatoid arthritis: superoxide anion, neutrophil chemotactic activity and fibronectin generation by alveolar macrophages. Eur Respir J1989;2(1):7–13.
54.
HunninghakeGW, GarrettKC, RichersonHB, FantoneJC, WardPA, RennardSI, et al. Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis1984;130(8):476–496.
55.
SongWD, ZhangAC, PangYY, LiuLH, ZhaoJY, DengSH, ZhangSY. Fibronectin and hyaluronan in bronchoalveolar lavage fluid from young patients with chronic obstructive pulmonary diseases. Respiration1995;62(3):125–129.
56.
GriggJ, van den BorreC, MalfrootA, PierardD, WangD, DabI.Bilateral fiberoptic bronchoalveolar lavage in acute unilateral lobar pneumonia. J Pediatr1993;122(4):606–608.
57.
BaughmanRP, DohnMN, LoudonRG, FramePT. Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections. Chest1991;99(1):92–97.
LieskeTR, SunderrajanEV, PassamontePM. Bronchoalveolar lavage and technetium-99m glucoheptonate imaging in chronic eosinophilic pneumonia. Chest1984;85(2):282–284.
60.
SutherlandKR, SteinbergKP, MaunderRJ, MilbergJA, AllenDL, HudsonLD. Pulmonary infection during the acute respiratory distress syndrome. Am J Respir Crit Care Med1995;152(2):550–556.
61.
MartinRJ, CoalsonJJ, RogersRM, HortonFO, ManousLE. Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis1980;121(5):819–825.
62.
StrumpfIJ, FeldMK, CorneliusMJ, KeoghBA, CrystalRG. Safety of fiberoptic bronchoalveolar lavage in evaluation of interstitial lung disease. Chest1981;80(3):268–271.
63.
SpringmeyerSC. The clinical use of bronchoalveolar lavage [editorial]. Chest1987;92(5):771–772.
64.
StollerJK, RankinJA, ReynoldsHY. The impact of bronchoalveolar lavage cell analysis on clinicians’ diagnostic reasoning about interstitial lung disease. Chest1987;92(5):839–843.
65.
CredleWFJr, SmiddyJF, ElliottRC. Complications of fiberoptic bronchoscopy. Am Rev Respir Dis1974;109(1):67–72.
66.
WiddicombeJG. Reflexes from the lungs and the respiratory tract. B M Bull1963;19:15–20.
67.
ZavalaDC, GodseyK, BedellGN. The response to atropine sulfate given by aerosol and intramuscular routes to patients undergoing fiberoptic bronchoscopy. Chest1981;79(5):512–515.
68.
PereiraW, KonvatDM, KahnMA, JacovinoJR, SpivackML, SniderGL. Fever and pneumonia after fiberoptic bronchoscopy. Am Rev Respir Dis1975;112:59–64.
69.
ShraderDL, LakshminarayanS.The effect of fiberoptic bronchoscopy on cardiac rhythm. Chest1978;73(6):821–824.
70.
KaretzkyMS, GarveyJW, BrandstetterRD. Effect of fiberoptic bronchoscopy on arterial oxygen tension. NY State J Med1974;74(1):62–63.
71.
LinCC, WuJL, HuangWC. Pulmonary function in normal subjects after bronchoalveolar lavage. Chest1988;93(5):1049–1053.
de FijterJW, van der HoevenJG, EggelmeijerF, MeindersAE. Sepsis syndrome and death after bronchoalveolar lavage. Chest1993;104 (4):1296–1297.
74.
ShepherdKE, LynchKE, WainJC, BrownEN, WilsonRS. Elastin fibers and the diagnosis of bacterial pneumonia in the adult respiratory distress syndrome. Crit Care Med1995;23:1829–1834.
75.
Centers for Disease Control and Prevention. Annual summary 1982: reported morbidity and mortality in the United States. MMWR Morb Mortal Wkly Rep1983;31:110–111.
76.
FangGD, FineM, OrloffJ, ArisumiD, YuVL, KapoorW.New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine Baltimore1990;69(5):307–316.
77.
TewJ, CalenoffL, BerlinBS. Bacterial or nonbacterial pneumonia: accuracy for radiographic diagnosis. Radiology1977;124(3):607–612.
78.
AderayeG.The value of sputum gram stain in the diagnosis of pneumococcal pneumonia. Ethiop Med J1994;32(3):167–171.
79.
DavidsonM, TempestB, PalmerDL. Bacteriologic diagnosis of acute pneumonia. Comparison of sputum, transtracheal aspiration, and lung aspirates. JAMA1976;235(2):158–163.
80.
JollietP, ChevroletJC. Bronchoscopy in the intensive care unit. Intensive Care Med1992;18(3):160–169.
81.
BaselskiVS, WunderinkRG. Bronchoscopic diagnosis of pneumonia. Clin Microbiol Rev1994;7(4):533–558.
82.
VallesJ, RelloJ, FernandezR, BlanchL, BaigorriF, MestreJ, et al. Role of bronchoalveolar lavage in mechanically ventilated patients with suspected pneumonia. Eur J Clin Microbiol Infect Dis1994;13(7):549–558.
83.
JordanGW, WongGA, HoeprichPD. Bacteriology of the lower respiratory tract as determined by fiberoptic bronchoscopy and transtracheal aspiration. J Infect Dis1976;134(5):428–435.
84.
WorthH, SchmitzKF, KrechT, HermelerH, HorschR, MullerF, et al. Detection of pathogens in bronchoalveolar lavage fluid in patients with pneumonias. Prax Klin Pnuemol1988;42(3):106–108.
85.
BroughtonWA, MiddletonRM3d, KirkpatrickMB, BassJBJr. Bronchoscopic protected specimen brush and bronchoalveolar lavage in the diagnosis of bacterial pneumonia. Infect Dis Clin North Am1991;5(3):437–452.
86.
PapazianL, MartinC, MericB, DumonJF, GouinF.A reappraisal of blind bronchial sampling in the microbiologic diagnosis of nosocomial bronchopneumonia. A comparative study in ventilated patients. Chest1993;103(1):236–242.
87.
CookDJ, Brun BuissonC, GuyattGH, SibbaldWJ. Evaluation of new diagnostic technologies: bronchoalveolar lavage and the diagnosis of ventilator-associated pneumonia. Crit Care Med1994;22(8):1314–1322.
88.
Sole-ViolanJ, Rodriguez de CastroF, ReyA, Martin-GonzalezJC, Cabrera-NavarroP.Usefulness of microscopic examination of intracellular organisms in lavage fluid in ventilator-associated pneumonia. Chest1994;106(3):889–894.
89.
SomuN, SwaminathanS, ParamasivanCN, VijayasekaranD, ChandrabhooshanamA, VijayanVK, PrabhakarR.Value of bronchoalveolar lavage and gastric lavage in the diagnosis of pulmonary tuberculosis in children. Tuber Lung Dis1995;76(4):295–299.
90.
de GraciaJ, CurullV, VidalR, RibaA, OrriolsR, MartinN, MorellF.Diagnostic value of bronchoalveolar lavage in suspected pulmonary tuberculosis. Chest1988;93(2):329–332.
91.
PangJA, ChanHS, ChanCY, CheungSW, FrenchGL. A tuberculostearic acid assay in the diagnosis of sputum smear-negative pulmonary tuberculosis: A prospective study of bronchial aspirate and lavage specimens. Ann Intern Med1989;111(8):650–654.
92.
RajaA, BaughmanRP, DanielTM. The detection by immunoassay of antibody to mycobacterial antigens and cycobacterial antigens in bronchoalveolar lavage fluid from patients with tuberculosis and control subjects. Chest1988;94(1):133–137.
93.
MartinWJ2d, SmithTF. Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol1986;23(6):1006–1008.
94.
ParadisIL, GrgurichWF, DummerJS, DekkerA, DauberJH. Rapid detection of cytomegalovirus pneumonia from lung lavage cells. Am Rev Respir Dis1988;138(3):697–702.
95.
WoodsGL, ThompsonAB, RennardSL, LinderJ.Detection of cytomegalovirus in bronchoalveolar lavage specimens. Spin amplification and staining with a monoclonal antibody to the early nuclear antigen for diagnosis of cytomegalovirus pneumonia. Chest1990;98(3):568–575.
96.
SolansEP, GarrityERJr, McCabeM, MartinezR, HusainAN. Early diagnosis of cytomegalovirus pneumonitis in lung transplant patients. Arch Pathol Lab Med1995;119(1):33–35.
97.
HilborneLH, NiebergRK, ChengL, LewinKJ. Direct in situ hybridization for rapid detection of cytomegalovirus in bronchoalveolar lavage. Am J Clin Pathol1987;87(6):766–769.
98.
MeterskyML, HarrellJH2d, MoserKM. Lack of utility of bronchial brush biopsy in patients infected with the human immunodeficiency virus. Chest1992;101(3):680–683.
99.
FlintA, BeckwithAL, NaylorB.Pneumocystis carinii pneumonia. Cytologic manifestations and rapid diagnosis in routinely prepared Papanicolaou-stained preparations. Am J Med1986;81(6):1009–1011.
100.
DuganJM, AvitabileAM, RossmanMD, ErnstCS, AtkinsonBF. Diagnosis of Pneumocystis carinii pneumonia by cytologic evaluation of Papanicolaou-stained bronchial specimens. Diagn Cytopathol1988;4(2):106–112.
101.
KimH-K, HughesWT. Comparison of methods for identification of Pneumocystis carinii in pulmonary aspirates. Am J Clin Pathol1973;60(4):462–466.
102.
LeibovitzE, PollackH, RigaudM, KaulA, PersaudD, GalloL, et al. Polymerase chain reaction is more sensitive than standard cytologic stains in detecting Pneumocystis carinii in bronchoalveolar lavages from human immunodeficiency virus type 1-infected infants and children with pneumonia. Pediatr Infect Dis J1995;14(8):714–716.
103.
ChechaniV, AllamAA, HaseebMA, KamholzSL. Pneumocystis carinii pneumonia in patients with AIDS: evaluation of lavage and staining techniques in diagnosis. J Acquir Immune Defic Syndr1991;4(3):250–253.
104.
BartlettJG, FinegoldSM. Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates. Am Rev Respir Dis1978;117(6):1019–1027.
105.
BaselskiV.Microbiologic diagnosis of ventilator-associated pneumonia. Infect Dis Clin North Am1993;7(2):331–357.
106.
ScheldWM, MandellGL. Nosocomial pneumonia: pathogenesis and recent advances in diagnosis and therapy. Rev Infect Dis1991;13(Suppl 9):S743–S751.
107.
MarquetteCH, CopinMC, WalletF, NeviereR, SaulnierF, MathieuD, et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med1995;151(6):1878–1888.
108.
SternbergRI, BaughmanRP, DohnMN, FirstMR. Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients. Am J Med1993;95(4):358–364.
109.
FossieckBEJr, ParkerRH, CohenMH, KaneRC. Fiberoptic bronchoscopy and culture of bacteria from the lower respiratory tract. Chest1977;72(1):5–9.
110.
Roger-MoreauI, de BarbeyracB, DucoudreM, HilbertG, Gbikpi-BenissanG, CardinaudJP, BebearC.Evaluation of bronchoalveolar lavage for the diagnosis of bacterial pneumonia in ventilated patients. Ann Biol Clin Paris1992;50(8):587–591.
111.
PapazianL, ThomasP, GarbeL, GuignonI, ThirionX, CharrelJ, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med1995;152(6, Part 1):1982–1991.
112.
TimsitJF, MissetB, GoldsteinFW, VauryP, CarletJ.Reappraisal of distal diagnostic testing in the diagnosis of ICU-acquired pneumonia. Chest1995;108(6):1632–1639.
113.
TorresA, el EbiaryM, PadroL, GonzalezJ, de la BellacasaJP, RamirezJ, et al. Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med1994;149(2, Part 1):324–331.
114.
ChastreJ, FagonJY, LamerC.Procedures for the diagnosis of pneumonia in ICU patients. Intensive Care Med1992;18(Suppl 1):S10–17.
115.
JimenezP, SaldiasF, MenesesM, SilvaME, WilsonMG, OtthL.Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia. Comparison between bronchoalveolar lavage and telescoping plugged catheter cultures. Chest1993;103(4):1023–1027.
116.
Sole-ViolanJ, Rodriguez de CastroF, Caminero-LunaJ, Bordes-BenitezA, Manzano-AlonsoJL. Comparative efficacy of bronchoalveolar lavage and telescoping plugged catheter in the diagnosis of pneumonia in mechanically ventilated patients. Chest1993;103(2):386–390.
117.
SpeichR, WustJ, HessT, KayserFH, RussiEW. Prospective evaluation of a semiquantitative dip slide method compared with quantitative bacterial cultures of BAL fluid. Chest1996;109(6):1423–1429.
118.
RiedlerJ, GriggJ, RobertsonCF. Role of bronchoalveolar lavage in children with lung disease. Eur Respir J1995;8(10):1725–1730.
119.
YagodaMR, StavolaJ, WardR, SteinbergC, JonesJ.Role of bronchoalveolar lavage in hospitalized pediatric patients. Ann Otol Rhinol Laryngol1996;105(11):863–867.
120.
SorensenJ, ForsbergP, HakansonE, MallerR, SederholmC, SorenL, CarlssonC.A new diagnostic approach to the patient with severe pneumonia. Scand J Infect Dis1989;21(1):33–41.
121.
TorresA, MartosA, Puig de la BellacasaJ, FerrerM, el EbiaryM, GonzalezJ, GeneA, Rodriguez-RoisinR.Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients. Am Rev Respir Dis1993;147(4):952–957.
122.
RoubyJJ, RossignonMD, NicolasMH, Martin de LassaleE, CristinS.A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. Anesthesiology1989;71(5):679–685.
123.
MeduriGU, BealsDH, MaijubAG, BaselskiV.Protected bronchoalveolar lavage. A new bronchoscopic technique to retrieve uncontaminated distal airway secretions. Am Rev Respir Dis1991;143(4, Part 1):855–864.
124.
HumphreysH, WinterR, BakerM, SmithC.Comparison of bronchoalveolar lavage and catheter lavage to confirm ventilator-associated lower respiratory tract infection. J Med Microbiol1996;45(3):226–231.
125.
PuginJ, AuckenthalerR, MiliN, JanssensJP, LewPD, SuterPM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis1991;143(5, Part 1):1121–1129.
126.
RicouB, GrandinS, NicodL, ThorensJB, SuterPM. Adult and paediatric size bronchoscopes for bronchoalveolar lavage in mechanically ventilated patients: yield and side effects. Thorax1995;50(3):290–293.
127.
KimTC, BlackmanRS, HeatwoleKM, KimT, RochesterDF. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment. Am Rev Respir Dis1984;129(2):264–268.
128.
CharoenratanakulS, DejsomritrutaiW, ChaiprasertA.Diagnostic role of fiberoptic bronchoscopy in suspected smear negative pulmonary tuberculosis. Respir Med1995;89(9):621–623.
129.
IpM, ChauPY, SoSY, LamWK. The value of routine bronchial aspirate culture at fibreoptic bronchoscopy for the diagnosis of tuberculosis. Tubercle1989;70(4):281–285.
130.
LevyH, FeldmanC, KallenbachJM. The diagnostic yield of prebronchoscopy sputa and bronchial washings in patients with biopsy-proven pulmonary tuberculosis. S Afr Med J1989;75(11):527–528.
131.
MohanA, PandeJN, SharmaSK, RattanA, GuleriaR, KhilnaniGC. Bronchoalveolar lavage in pulmonary tuberculosis: a decision analysis approach. QJM1995;88(4):269–276.
132.
SchmidtRM, RosenkranzHS. Antimicrobial activity of local anesthetics: lidocaine and procaine. J Infect Dis1970;121(6):597–607.
133.
MeduriGU, BaselskiV.The role of bronchoalveolar lavage in diagnosing nonopportunistic bacterial pneumonia. Chest1991;100(1):179–190.
134.
SharmaSK, PandeJN, VermaK.Bronchoalveolar lavage (BAL) in miliary tuberculosis. Tubercle1988;69(3):175–178.
135.
ChanCH, ChanRC, ArnoldM, CheungH, CheungSW, ChengAF. Bronchoscopy and tuberculostearic acid assay in the diagnosis of sputum smear-negative pulmonary tuberculosis: a prospective study with the addition of transbronchial biopsy. Q J Med1992;82(297):15–23.
136.
OsumiM, ToyodaT, KawashiroT, AoyagiT.Detection of Mycobacterium tuberculosis in clinical specimens other than sputum by a specific DNA probe with amplification of the ribosomal RNA. Kansenshogaku Zasshi1995;69(12):1376–1382.
137.
PushpakomR, BoronkittisS, Ong-ajyuthS, VanittankomN.Adenosine deaminase activity in bronchoalveolar lavage fluids: Test for diagnosing of pulmonary tuberculosis. Thia J Tuberc Chest Dis1988;9:63–79.
138.
AlberaC, MabrittoI, GhioP, SolidoroP, MarchettiL, PozziE.Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis. Sarcoidosis1993;10(1):18–25.
139.
HoheiselGB, TabakL, TeschlerH, ErkanF, KroegelC, CostabelU.Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis. Am J Respir Crit Care Med1994;149(2, Part 1):460–463.
140.
YuCT, WangCH, HuangTJ, LinHC, KuoHP. Relation of bronchoalveolar lavage T lymphocyte subpopulations to rate of regression of active pulmonary tuberculosis. Thorax1995;50(8):869–874.
141.
LawK, WeidenM, HarkinT, Tchou-WongK, ChiC, RomWN. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med1996;153 (2):799–804.
142.
HoheiselG, ZhengL, TeschlerH, StrizI, CostabelU.Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. Chest1995;108(6):1614–1616.
143.
RimmerJ, GibsonP, BryantDH. Extension of pulmonary tuberculosis after fibreoptic bronchoscopy. Tubercle1988;69(1):57–61.
144.
ReevesDS, BrownNM. Mycobacterial contamination of fiberoptic bronchoscopes. J Hosp Infect1995;30(Suppl):531–536.
145.
LiebermanD, PorathA, SchlaefferF, LiebermanD, BoldurI.Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients. Chest1996;109(5):1243–1249.
146.
TsaiTF, FraserDW. The diagnosis of Legionnaires’ disease. Ann Intern Med1978;89(3):413–414.
147.
KohorstWR, SchonfeldSA, MacklinJE, WhitcombME. Rapid diagnosis of Legionnaires’ disease by bronchoalveolar lavage. Chest1983;84(2):186–190.
148.
WinnWCJr, PasculleAW. Laboratory diagnosis of infections caused by Legionella species. Clin Lab Med1982;2(2):343–369.
149.
CrawfordSW, BowdenRA, HackmanRC, GleavesCA, MeyersJD, ClarkJG. Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture. Ann Intern Med1988;108(2):180–185.
150.
MasihA, RennardSI, BinkleyLI, ThomsonAB, LinderJ.Detection of cytomegalovirus in bronchoalveolar lavage specimens by cytology, tissue culture, fluorescent monoclonal antibodies and in situ hybridization. Acta Cytologica1987;31(5):648.
151.
MandanasRA, SaezRA, SelbyGB, ConferDL. Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy. Am J Hematol1996;51(2):104–111.
152.
HaynerCE, BaughmanRP, LinnemannCCJr, DohnMN. The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV. Chest1995;107(3):735–740.
153.
CathomasG, MorrisP, PekleK, CunninghamI, EmanuelD.Rapid diagnosis of cytomegalovirus pneumonia in marrow transplant recipients by bronchoalveolar lavage using the polymerase chain reaction, virus culture, and the direct immunostaining of alveolar cells. Blood1993;81(7):1909–1914.
154.
DelvenneP, ArreseJE, ThiryA, Borlee-HermansG, PierardGE, BoniverJ.Detection of cytomegalovirus, Pneumocystis carinii, and Aspergillus species in bronchoalveolar lavage fluid. A comparison of techniques. Am J Clin Pathol1993;100(4):414–418.
155.
SmithB, VergheseA, GuiterrezC, DralleW, BerkSL. Pulmonary strongyloidiasis. Diagnosis by sputum gram stain. Am J Med1985;79 (5):663–666.
156.
VenizelosP, LopataM, BardawilWA, SharpJT. Respiratory failure due to Strongyloides stercoralis in a patient with a renal transplant. Chest1980;78:104–106.
157.
FroesHP. Identification of Nematoda larva in exudate of serohemorrhagic pleural effusion. J Trop Med1930;33:18–19.
158.
WilliamsJ, NunleyD, DralleW, BerkSL, VergheseA.Diagnosis of pulmonary strongyloidiasis by bronchoalveolar lavage. Chest1988;94(3):643–644.
159.
RemadiS, DumaisJ, WafaK, MacGeeW.Pulmonary microsporidiosis in a patient with the acquired immunodeficiency syndrome. A case report. Acta Cytol1995;39(6):1112–1116.
160.
FisherBD, ArmstrongD, YuB, GoldJW. Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med1981;71(4):571–577.
161.
HahnHH, BeatyHN. Transtracheal aspiration in the evaluation of patients with pneumonia. Ann Intern Med1970;72(2):183–187.
162.
PenningtonJE. Aspergillus pneumonia in hematologic malignancy. Improvements in diagnosis and therapy. Arch Intern Med1977;137(6):769–771.
163.
von EiffM, RoosN, SchultenR, HesseM, ZuhlsdorfM, van de LooJ.Pulmonary aspergillosis: early diagnosis improves survival. Respiration1995;62(6):341–347.
164.
KahnFW, JonesJM, EnglandDM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol1986;86(4):518–523.
165.
CazzadoriA, Di PerriG, TodeschiniG, LuzzatiR, BoschieroL, PeronaG, ConciaE.Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest1995;107(1):101–106.
166.
EllisME, SpenceD, BouchamaA, AntoniusJ, BazarbashiM, KhougeerF, De VolEB. Open lung biopsy provides a higher and more specific diagnostic yield compared to bronchoalveolar lavage in immunocompromised patients. Fungal Study Group. Scand J Infect Dis1995;27(2):157–162.
167.
HopkinsJM, YoungJA, TurneyJH, MichaelJ, AdvaD.Rapid diagnosis of obscure pneumonia in immunosuppressed renal patients by cytology or alveolar lavage fluid. Lancet1983;2(8345):299–301.
168.
GallardoJ, SasalM, FerreresJC. Diagnosis of histoplasmosis in bronchoalveolar lavage fluid [letter] Acta Cytol1995;39(3):595–596.
169.
von EiffM, ZuhlsdorfM, RoosN, HesseM, SchultenR, van de LooJ.Pulmonary fungal infections in patients with hematological malignancies-diagnostic approaches. Ann Hematol1995;70(3):135–141.
170.
LewinSR, HoyJ, CroweSM, McDonaldCF. The role of bronchoscopy in the diagnosis and treatment of pulmonary disease in HIV-infected patients. Aust N Z J Med1995;25(2):133–139.
171.
PinkstonP, PelletierN, ArenaC, SchockJ, GarlandR, RoseRM. Quantitative culture of HIV-1 from bronchoalveolar lavage cells. Am J Respir Crit Care Med1995;152(1):254–259.
172.
TaylorIK, CokerRJ, ClarkeJ, MossFM, NiemanR, EvansDJ, et al. Pulmonary complications of HIV disease: 10 year retrospective evaluation of yields from bronchoalveolar lavage, 1983-93. Thorax1995;50(12):1240–1245.
173.
von EiffM, SchlingheiderO, SchulzeF, ZuhlsdorfM, van de LooJ.Differential cell count and lymphocyte subsets in bronchoalveolar lavage during pneumonia with and without peripheral neutropenia. Lung1995;173(1):25–33.
DeVitaVT, EmmerM, LevineA, JacobsB, BerardC.Pneumocystis carinii pneumonia: Successful diagnosis and treatment of two patients with associated malignant processes. N Engl J Med1969;280(6):287–291.
176.
JohnsonHD, JohnsonWW. Pneumocystic carinii pneumonia in children with cancer: Diagnosis and treatment. JAMA1970;214(6):1067–1073.
177.
RepsherLH, SchroterG, HammondWS. Diagnosis of Pneumocystis carinii pneumonitis by means of endobronchial brush biopsy. N Engl J Med1972;287(7):340–341.
178.
MartinWR, AlbertsonTE, SiegelB.Tracheal catheters in patients with acquired immunodeficiency syndrome for the diagnosis of Pneumocystis carinii pneumonia. Chest1990;98(1):29–32.
179.
KirschCM, AzziRL, YenokidaGG, JensenWA. Analysis of induced sputum in the diagnosis of Pneumocystis carinii pneumonia. Am J Med Sci1990;299(6):386–391.
180.
NormanL, KaganIG. Some observations on the serology of Pneumocystis carinii infections in the United States. Infect Immun1973;8(3):317–321.
181.
del RioC, GuarnerJ, HonigEG, SladeBA. Sputum examination in the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Pathol Lab Med1988;112(12):1229–1232.
182.
LeighTR, ParsonsP, HumeC, HusainOA, GazzardB, CollinsJV. Sputum induction for diagnosis of Pneumocystis carinii pneumonia. Lancet1989;2(8656):205–206.
183.
ChouaidC, HoussetB, PoirotJL, RouxP, LebeauB.Cost effectiveness of the induced sputum technique for the diagnosis of Pneumocystis carinii pneumonia (PCP) in HIV-infected patients. Eur Respir J1993;6(2):248–252.
184.
DrewWL, FinleyTN, MintzL, KleinHZ. Diagnosis of Pneumocystis carinii pneumonia by bronchopulmonary lavage. JAMA1974;230(5):713–715.
185.
GoldenJA, HollanderH, StulbargMS, GamsuG.Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia. A prospective study among patients with acquired immunodeficiency syndrome. Chest1986;90(1):18–22.
186.
OrensteinM, WebberCA, HeurichAE. Cytologic diagnosis of Pneumocystis carinii infection by bronchoalveolar lavage in acquired immune deficiency syndrome. Acta Cytol1985;29(5):727–731.
187.
TileySM, MarriottDJ, HarknessJL. An evaluation of four methods for the detection of Pneumocystis carinii in clinical specimens. Pathology1994;26(3):325–328.
188.
ArmbrusterC, PokieserL, HasslA.Diagnosis of Pneumocystis carinii pneumonia by bronchoalveolar lavage in AIDS patients. Comparison of Diff-Quik, fungifluor stain, direct immunofluorescence test and polymerase chain reaction. Acta Cytol1995;39(6): 1089–1093.
189.
ElvinKM, BjorkmanA, LinderE, HeurlinN, HjerpeA.Pneumocystis carinii pneumonia: detection of parasites in sputum and bronchoalveolar lavage fluid by monoclonal antibodies. BMJ1988;297 (6645):381–384.
190.
WazirJF, MacrorieSG, ColemanDV. Evaluation of the sensitivity, specificity, and predictive value of monoclonal antibody 3F6 for the detection of Pneumocystis carinii pneumonia in bronchoalveolar lavage specimens and induced sputum. Cytopathology1994;5(2):82–89.
191.
LeibovitzE, PollackH, MooreT, PapellasJ, GalloL, KrasinskiK, BorkowskyW.Comparison of PCR and standard cytological staining for detection of Pneumocystis carinii from respiratory specimens from patients with or at high risk for infection by human immunodeficiency virus. J Clin Microbiol1995;33(11):3004–3007.
192.
TorringtonKG, FinelliMR. Small volume bronchoalveolar lavage used in diagnosing Pneumocystis carinii pneumonia in HIV-infected patients. Chest1995;107(4):1013–1017.
193.
TamburriniE, MencariniP, De LucaA, MaiuroG, VenturaG, AntinoriA, et al. Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens. J Med Microbiol1993;38(6):449–453.
194.
SternbergRI, WhitsettJA, HullWM, BaughmanRP. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid. J Lab Clin Med1995;125(4):462–469.
195.
GadeaI, CuencaM, BenitoN, PeredaJM, SorianoF.Bronchoalveolar lavage for the diagnosis of disseminated toxoplasmosis in AIDS patients. Diagn Microbiol Infect Dis1995;22(4):339–341.
196.
ContiniC, RomaniR, MagnoS, DeliaS.Diagnosis of Toxoplasma gondii infection in AIDS patients by a tissue-culture technique. Eur J Clin Microbiol Infect Dis1995;14(5):434–440.
197.
MacMahonH, CourtneyJV, LittleAG. Diagnostic methods in lung cancer. Semin Oncol1983;10(1):20–33.
198.
SemenzatoG, PolettiV.Bronchoalveolar lavage in lung cancer. Respiration1992;59(Suppl 1):44–46.
199.
RennardSI. Bronchoalveolar lavage in the assessment of primary and metastatic lung cancer. Respiration1992;59(Suppl 1):41–43.
200.
WallaceRH, KolbeJ.Fibreoptic bronchoscopy and bronchoalveolar lavage in the investigation of the immunocompromised lung. N Z Med J1992;105(935):215–217.
201.
AbramsonMJ, StoneCA, HolmesPW, TaiEH. The role of bronchoalveolar lavage in the diagnosis of suspected opportunistic pneumonia. Aust N Z J Med1987;17(4):407–412.
202.
RennardSI. Bronchoalveolar lavage in the diagnosis of cancer. Lung1990;168(Suppl):1035–1040.
203.
SemenzatoG, SpataforaM, FeruglioC, PaceE, Di PietroV.Bronchoalveolar lavage and the immunology of lung cancer. Lung1990; 16:(Suppl):1041–1049.
204.
NoppenM, SlabbynckH, De WaeleM, LacorP, MonsieurI, VinckenW.Immunogold-silver staining of cells recovered by bronchoalveolar lavage. A report of three cases demonstrating its value in the diagnosis of pulmonary involvement in hematologic malignancies. Acta Cytol1995;39(6):1141–1147.
205.
LinderJ, RadioSJ, RobbinsRA, GhafouriM, RennardSI. Bronchoalveolar lavage in the cytologic diagnosis of carcinoma of the lung. Acta Cytol1987;31(6):796–801.
206.
Biyoudi-VouenzeR, TaziA, HanceAJ, ChastreJ, BassetF, SolerP.Abnormal epithelial cells recovered by bronchoalveolar lavage: are they malignant?. Am Rev Respir Dis1990;142(3):686–690.
de GraciaJ, BravoC, MiravitllesM, TalladaN, OrriolsR, BellmuntJ, et al. Diagnostic value of bronchoalveolar lavage in peripheral lung cancer. Am Rev Respir Dis1993;147(3):649–652.
210.
PirozynskiM.Bronchoalveolar lavage in the diagnosis of peripheral, primary lung cancer. Chest1992;102(2):372–374.
211.
RossiGA, BalbiB, RissoM, RepettoM, RavazzoniC.Acute myelomonocytic leukemia. Demonstration of pulmonary involvement by bronchoalveolar lavage. Chest1985;87(2):259–260.
212.
MenasheP, StensonW, ReynosoG, KeaneM, NairKG, NelsonG.Bronchoalveolar lavage plasmacytosis in patient with a plasma cell dyscrasia. Chest1989;95(1):226–227.
213.
MillerKS, SahnSA. Mycosis fungoides presenting as ARDS and diagnosed by bronchoalveolar lavage. Radiographic and pathologic pulmonary manifestations. Chest1986;89(2):312–314.
214.
KobayashiH, Ii K, HizawaK, MaedaT.Two cases of pulmonary Waldenstrom's macroglobulinemia. Chest1985;88(2):297–299.
215.
GallagherCJ, KnowlesGK, HabeshawJA, GreenM, MalpasJS, ListerTA. Early involvement of the bronchi in patients with malignant lymphoma. Br J Cancer1983;48(6):777–781.
216.
MoralesFM, MatthewsJI. Diagnosis of parenchymal Hodgkin's disease using bronchoalveolar lavage. Chest1987;91(5):785–787.
217.
OkaM, KawanoK, KandaT, HaraK.Bronchoalveolar lavage in primary pulmonary lymphoma with monoclonal gammopathy. Am Rev Respir Dis1988;137(4):957–959.
218.
KeichoN, OkaT, TakeuchiK, YamaneA, YazakiY, YotsumotoH.Detection of lymphomatous involvement of the lung by bronchoalveolar lavage. Application of immunophenotypic and gene rearrangement analysis. Chest1994;105(2):458–462.
219.
DavisWB, GadekJE. Detection of pulmonary lymphoma by bronchoalveolar lavage. Chest1987;91(5):787–790.
220.
PisaniRJ, WitzigTE, LiCY, MorrisMA, ThibodeauSN. Confirmation of lymphomatous pulmonary involvement by immunophenotypic and gene rearrangement analysis of bronchoalveolar lavage fluid. Mayo Clin Proc1990;65(5):651–656.
221.
MaejimaS, KitanoK, IchikawaS, KanekoT, SaitoH, KiyosawaK, FurutaS.T-cell non-Hodgkin's lymphoma of the lung. Intern Med1993;32(5):403–407.
222.
PolettiV, RomagnaM, GasponiA, BaruzziG, AllenKA. Bronchoalveolar lavage in the diagnosis of low-grade, MALT type, B-cell lymphoma in the lung. Monaldi Arch Chest Dis1995;50(3):191–194.
223.
Winer-MuramHT, RubinSA, KauffmanWM, JenningsSG, ArheartKL, SandlundJT, BozemanPM. Childhood lymphoma: diagnostic accuracy of chest radiography for severe pulmonary complications. Clin Radiol1995;50(12):842–847.
224.
Rodriguez de CastroF, MoleroT, Julia-SerdaG, CamineroJ, CabreraP.DNA analysis of bronchoalveolar lavage in the diagnosis of pulmonary lymphoma. Respiration1995;62(6):359–360.
225.
VerstraetenA, SaultMC, WallaertB, LemonnierP, GosselinB, TonnelAB. Metastatic prostatic adenocarcinoma-diagnosed by bronchoalveolar lavage and tumour marker determination. Eur Respir J1991;4(10):1296–1298.
226.
FernandezK, O'HanlanKA, Rodriguez-RodriguezL, MarinoWD. Respiratory failure due to interstitial lung metastases of ovarian carcinoma reversed by chemotherapy. Chest1991;99(6):1533–1534.
227.
RadioSJ, RennardSI, KessingerA, VaughanWP, LinderJ.Breast carcinoma in bronchoalveolar lavage. A cytologic and immunocytochemical study. Arch Pathol Lab Med1989;113(4):333–336.
228.
MelloCJ, VeronikisI, FraireAE, AroninN, IrwinRS, BravermanLE. Metastatic papillary thyroid carcinoma to lung diagnosed by bronchoalveolar lavage. J Clin Endocrinol Metab1996;81(1):406–410.
229.
LevyH, HorakDA, LewisMI. The value of bronchial washings and bronchoalveolar lavage in the diagnosis of lymphangitic carcinomatosis. Chest1988;94(5):1028–1030.
230.
PolettiV, RomagnaM, AllenKA, GasponiA, SpigaL.Bronchoalveolar lavage in the diagnosis of disseminated lung tumors. Acta Cytol1995;39(3):472–477.
231.
Von EiffM, KochO, AppelhansN, RoosN, Van de LooJ.Diagnostic significance of the tumor markers CEA, SCC, and NSE in serum and bronchoalveolar lavage (Ger). Pneumologie1990;44:(Suppl):462–464.
232.
MacchiaV, MarianoA, CavalcantiM, CoppaA, CecereC, FraioliG, et al. Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin. Int J Biol Markers1987;2(3):151–156.
233.
HirakataY, KobayashiJ, SugamaY, KitamuraS.Elevation of tumour markers in serum and bronchoalveolar lavage fluid in pulmonary alveolar proteinosis. Eur Respir J1995;8(5):686–696.
234.
OhwadaA, TakahashiH, NagaokaI, IwabuchiK, MikamiO, KiraS.Effect of cigarette smoke on the mRNA and protein expression of carcinoembryonic antigen (CEA), a possible chemoattractant for neutrophils in human bronchoalveolar tissues. Thorax1995;50(6):651–657.
235.
SanguinettiCM, RiccioniG, MarchesaniF, PelaR, CecariniL.Bronchoalveolar lavage fluid level of carcinoembryonic antigen in the diagnosis of peripheral lung cancer. Monaldi Arch Chest Dis1995;50(3):177–182.
236.
Hernandez-HernandezJR, Garcia-GarciaJM, Martinez-MunizMA, Allende-MonclusMT, Ruibal-MorellA.Clinical utility of hyaluronic values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma. Int J Biol Markers1995;10(3):149–155.
237.
MillsNE, FishmanCL, ScholesJ, AndersonSE, RomWN, JacobsonDR. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J Natl Cancer Inst1995;87(14):1056–1060.
238.
PisaniRJ, CorteseDA, HomburgerHA, GrambschPM. A prospective pilot study evaluating the effectiveness of secretory IgA measurements in bronchoalveolar lavage to detect non-small cell lung cancer. Chest1990;97(3):586–589.
239.
LefeverA, FunahashiA.Elevated prostaglandin E2 levels in bronchoalveolar lavage fluid of patients with bronchogenic carcinoma. Chest1990;98(6):1397–1402.
240.
SahnSA, ScogginC.Fiberoptic bronchoscopy in bronchial asthma. A word of caution. Chest1976;69(1):39–42.
241.
RoismanGL, LacroniqueJG, Desmazes-DufenN, CarreC, Le CaeA, DusserDJ. Airway responsiveness to bradykinin is related to eosinophilic inflammation in asthma. Am J Respir Crit Care Med1996;153(1):381–390.
242.
BenseinIL, BousheyHA, CherniackRM. Summery and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatic patients. Chest1985;88:136–138.
243.
MichelFB, GodardP, BousquetJ.Usefulness of bronchoalveolar lavage in asthmatics. The right clinical practice. Int Arch Allergy Appl Immunol1989;88(1-2):101–107.
244.
YousefiS, HemmannS, WeberM, HolzerC, HartungK, BlaserK, SimonHU. IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol1995;154 (10):5481–5490.
245.
WardlawAJ, DunnetteS, GleichGJ, CollinsJV, KayAB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis1988; 137(1):62–69.
246.
RobinsonDS, AssoufiB, DurhamSR, KayAB. Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment. Clin Exp Allergy1995;25(11):1118–1127.
247.
JoosGF, KipsJC, PelemanRA, PauwelsRA. Tachykinin antagonists and the airways. Arch Int Pharmacodyn Ther1995;329(1):205–219.
248.
HeaneyLG, CrossLJ, StanfordCF, EnnisM.Substance P induces histamine release from human pulmonary mast cells. Clin Exp Allergy1995;25(2):179–186.
249.
JarjourNN, BusseWW. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. Am J Respir Crit Care Med1995;152 (5, Part 1):1474–1477.
250.
GurdAR. Fat embolism: an aid to diagnosis. J Bone Joint Surg Br1970;52(4):732–737.
251.
GosslingHR, DonohueTA. The fat embolism syndrome. JAMA1979;241(25):2740–2742.
252.
LepistoP, AlhoA.Diagnostic features of the fat embolism syndrome. Acta Chir Scand1975;141(4):245–250.
253.
RogerN, XaubetA, AgustiC, ZabalaE, BallesterE, TorresA, et al. Role of bronchoalveolar lavage in the diagnosis of fat embolism syndrome. Eur Respir J1995;8(8):1275–1280.
254.
LambertSB, Frazier-JessenMR, VanStedumS, HahnEL, FilkinsJP, GarrityER, KovacsEJ. Bronchoalveolar lavage fluid endotoxin elevation in human single lung transplant recipients during rejection. Transpl Immunol1995;3(1):81–85.
255.
WilkesDS, HeidlerKM, NiemeierM, SchwenkGR, MathurPN, BreiteWM, et al. Increased bronchoalveolar IgG2/IgG1 ratio is a marker for human lung allograft rejection. J Investig Med1994;42(4):652–659.
256.
BernardGR, ArtigasA, BrighamKL, CarletJ, FalkeK, HudsonL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med1994;149(3, Part 1):818–824.
257.
SnyderLS, HertzMI, HarmonKR, BittermanPB. Failure of lung repair following acute lung injury. Regulation of the fibroproliferative response (Part 1). Chest1990;98(3):733–738.
258.
HyersTM, TricomiSM, DettenmeierPA, FowlerAA. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis1991;144(2):268–271.
259.
StrieterRM, LynchJP3rd, BashaMA, StandifordTJ, KasaharaK, KunkelSL. Host responses in mediating sepsis and adult respiratory distress syndrome. Semin Respir Infect1990;5(3):233–247.
260.
MeduriGU, KohlerG, HeadleyS, TolleyE, StentzF, PostlethwaiteA.Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest1995;108(5):1303–1314.
261.
ModigJ, HallgrenR.Pathophysiologic significance of lung granulocytes in human adult respiratory distress syndrome induced by septic or traumatic shock. Acta Chir Scand1987;153(4):267–271.
262.
LeeCT, FeinAM, LippmannM, HoltzmanH, KimbelP, WeinbaumG.Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N Engl J Med1981;304(4):192–196.
263.
WewersMD, HerzykDJ, GadekJE. Alveolar fluid neutrophil elastase activity in the adult respiratory distress syndrome is complexed to alpha-2-macroglobulin. J Clin Invest1988;82(4):1260–1267.
264.
Krsek-StaplesJA, KewRR, WebsterRO. Ceruloplasmin and transferrin levels are altered in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis1992;145(5):1009–1015.
265.
LykensMG, DavisWB, PachtER. Antioxidant activity of bronchoalveolar lavage fluid in the adult respiratory distress syndrome. Am J Physiol1992;262 (2, Part 1):L169–175.
266.
MontgomeryAB, StagerMA, CarricoCJ, HudsonLD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis1985;132(3):485–489.
267.
BellRC, CoalsonJJ, SmithJD, JohansonWGJr. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med1983;99(3):293–298.
268.
LeeperKVJr. Diagnosis and treatment of pulmonary infections in adult respiratory distress syndrome. New Horiz1993;1(4):550–562.
269.
SteinbergKP, MitchellDR, MaunderRJ, MilbergJA, WhitcombME, HudsonLD. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Respir Dis1993;148(3):556–561.
270.
CrystalRG, BittermanPB, RennardSI, HanceAJ, KeoghBA. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med1984;310(3):154–166.
DhillonDP, HaslamPL, TownsendPJ, PrimettZ, CollinsJV, Turner-WarwickM.Bronchoalveolar lavage in patients with interstitial lung diseases. side effects and factors affecting fluid recovery. Eur J Respir Dis1986;68(5):342–350.
274.
CalvanicoNJ, AmbegaonkarSP, SchlueterDP, FinkJN. Immunoglobulin level in bronchoalveolar lavage fluid from pigeon breeds. J Lab Clin Med1980;96(1):129–140.
275.
CarringtonCB. Structure and function in sarcoidosis. Ann NY Acad Sci1976;278:265–283.
276.
SchlueterDP. Response of the lung to inhaled antigens. Am J Med1974;57(3):476–492.
277.
CarringtonCB, GaenslerEA, CoutuRE, FitzGeraldMX, GuptaRG. Natural history and treated course of usual and desquamative interstitial pneumonitis. N Engl J Med1978;298(15):801–809.
278.
PhillipsBA, CooperKR, FratkinMJ. Effect of bronchoscopy on localization of gallium-67 citrate. Am Rev Respir Dis1983;127(3):342–343.
XaubetA, MoisesJA, AgustiC, MartosJA, PicadoC.Identification of mast cells in bronchoalveolar lavage fluid. Comparison between different fixation and staining methods. Allergy1991;46(2):227.
CullenMR, MerrillWW. Association between neutrophil concentration in bronchoalveolar lavage fluid and recent losses in diffusing capacity in men formerly exposed to asbestos. Chest1992;102(3):682–687.
283.
IzumiT, KitaichiM, NishimuraK, NagaiS.Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest1992;102(3):715–719.
284.
PoppW, BraunO, RitschkaL, ScherakO, KolarzG, RauscherH, et al. Chest x-ray in collagen vascular diseases. A comparison of chest x-ray with bronchoalveolar lavage and transbronchial forceps biopsy. Respiration1994;61(3):138–143.
285.
WellsAU, HansellDM, RubensMB, CullinanP, HaslamPL, BlackCM, DuBoisRM. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med1994;150(2):462–468.
286.
AkounGM, CadranelJL, RosenowEC3d, MilleronBJ. Bronchoalveolar lavage cell data in drug-induced pneumonitis. Allerg Immunol Paris1991;23(6):245–252.
287.
KhardoriR, EagletonLE, SolerNG, McConnachiePR. Lymphocytic interstitial pneumonitis in autoimmune thyroid disease. Am J Med1991;90(5):649–652.
288.
RobertsCM, FoulcherE, ZaundersJJ, BryantDH, FreundJ, CairnsD, et al. Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med1993;118(9):696–700.
289.
DalavangaYA, ConstantopoulosSH, GalanopoulouV, ZervaL, MoutsopoulosHM. Alveolitis correlates with clinical pulmonary involvement in primary Sjogren's syndrome. Chest1991;99(6):1394–1397.
290.
SchlickW.Current issues in the assessment of interstitial lung disease. Monaldi Arch Chest Dis1993;48(3):237–244.
291.
RossN, DiederichS, von EiffM, VestringT, PetersPE. Computed tomography in noninfectious interstitial lung diseases. Radiologe1993;100:380–383.
RaghuG.Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient?Am J Respir Crit Care Med1995;151(3, Part 1):909–914.
294.
DrentM, van NieropMA, GerritsenFA, WoutersEF, MulderPG. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med1996;153 (2):736–741.
295.
WeinbergerSE, KelmanJA, ElsonNA, YoungRCJr, ReynoldsHY, FulmerJD, CrystalRC. Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med1978;89(4):459–466.
296.
WurtembergerG, DinkelE, CostabelU, MatthysH.The value of bronchoalveolar lavage in the diagnosis of interstitial lung diseases. Radiologe1990;30:557–563.
297.
ColeP, TurtonC, LanyonH, CollinsJ.Bronchoalveolar lavage for the preparation of free lung cells: technique and complications. Br J Dis Chest1980;74(3):273–278.
298.
NugentKM, PetersonMW, JollesH, MonickMM, HunninghakeGW. Correlation of chest roentgenograms with pulmonary function and bronchoalveolar lavage in interstitial lung disease. Chest1989;96(6):1224–1227.
MitchellDN, ScaddingJD. Sarcoidosis. Am Rev Respir Dis1974;110:774–802.
301.
MartinWJII, WilliamsDE, DinesDE, SandersonDR. Interstitial lung disease. Assessment by bronchoalveolar lavage. Mayo Clin Proc1983;58(11):751–757.
302.
DrentM, MulderPG, WagenaarSS, HoogstedenHC, va Velzen BladH, van den BoschJM. Differences in BAL fluid variables in interstitial lung diseases evaluated by discriminant analysis. Eur Respir J1993;6(6):803–810.
303.
HallgrenR, BjermerL, LundgrenR, VengeP.The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis1989;139(2):373–377.
304.
SchwartzDA, HelmersRA, DaytonCS, MerchantRK, HunninghakeGW. Determinants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosis. J Appl Physiol1991;71(5):1688–1693.
305.
WinterbauerRH, LammertJ, SellandM, WuR, CorleyD, SpringmeyerSC. Bronchoalveolar lavage cell populations in the diagno-sis of sarcoidosis. Chest1993;104(2):352–361.
306.
ShindohY, ShimuraS, TomiokaM, AikawaT, SasakiH, TakishimaT.Cellular analysis in bronchoalveolar lavage fluids in infiltrative and fibrotic stages of idiopathic pulmonary fibrosis. Tohoku J Exp Med1986;149(1):47–60.
307.
LawrenceEC, MartinRR, BlaeseRM, TeagueRB, AweRJ, Wil-sonRK, et al. Increased bronchoalveolar IgG-secreting cells in inter-stitial lung diseases. N Engl J Med1980;302(21):1186–1188.
308.
SpecksU, MartinWJ 2d, RohrbachMS. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. Am Rev Respir Dis1990;141(1):117–123.
309.
AllenRK, PierceRJ, BarterCE. Angiotensin-converting enzyme in bronchoalveolar lavage fluid in sarcoidosis. Sarcoidosis1992;9(1):54–59.
310.
BaumBJ, McDonaldJA, CrystalRG. Metabolic fate of the major cell surface protein of normal human fibroblasts. Biochem Biophys Res Commun1977;79(1):8–15.
311.
YamadaKM, OldenK.Fibronectins-adhesive glycoproteins of cell surface and blood. Nature1978;275(5677):179–184.
312.
MenendezR, MarcoV, RubioV, SoleA.Quantification of fibronectin in bronchoalveolar lavage fluid and in lung parenchyma: differences between smokers and non-smokers. Respiration1995;62(6):312–316.
313.
RennardSI, CrystalRG. Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. J Clin Invest1982;69(1):113–122.
314.
PohlWR, ConlanMG, ThompsonAB, ErtlRF, RombergerDJ, MosherDF, RennardSI. Vitronectin in bronchoalveolar lavage fluid is increased in patients with interstitial lung disease. Am Rev Respir Dis1991;143(6):1369–1375.
315.
AlamR, WelterJ, ForsytheP, BousquertJ, RankinJ, BoyarsM, et al. Histamine release inhibitory factors (HRIF) and histamine releas-ing factor (HRF) in bronchoalveolar lavage fluidsJ Allergy Clin Immunol1989;83 (Suppl):236S.
316.
BroideDH, SmithCM, WassermanSI. Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid. J Immunol1990;145(6):1838–1844.
317.
WallsAF, BennettAR, GodfreyRC, HolgateST, ChurchMK. Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease. Clin Sci Colch1991;81 (2):183–188.
318.
CasaleTB, TrappS, ZehrB, HunninghakeGW. Bronchoalveolar lavage fluid histamine levels in interstitial lung diseases. Am Rev Respir Dis1988;138(6):1604–1608.
319.
PesciA, BertorelliG, GabrielliM, OlivieriD.Mast cells in fibrotic lung disorders. Chest1993;103(4):989–996.
320.
HunninghakeGW, KalicaAR. Approaches to the treatment of pul-monary fibrosis. Am J Respir Crit Care Med1995;151(3, Part 1):915–918.
321.
Turner-WarwickM, BurrowsB, JohnsonA.Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax1980;35(3):171–180.
322.
StackBH, Choo-KangYF, HeardBE. The prognosis of cryptogenic fibrosing alveolitis. Thorax1972;27(5):535–542.
323.
WattersLC, KingTE, SchwarzMI, WaldronJA, StanfordRE, CherniackRM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis1986;133(1):97–103.
324.
HunninghakeGW, GadekJE, LawleyTJ, CrystalRG. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest1981;68(1):259–269.
325.
GadekJE, KelmanJA, FellsG, WeinbergerSE, HorwitzAL, ReynoldsHY, et al. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. N Engl J Med1979;301(14):737–742.
326.
CrystalRG, FulmerJD, BaumBJ, BernardoJ, BradleyKH, BruelSD, et al. Cells, collagen and idiopathic pulmonary fibrosis. Lung1978;155(3):199–224.
327.
HaslamPL, TurtonCW, LukoszekA, SalsburyAJ, DewarA, CollinsJV, Turner-WarwickM.Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Tho-rax1980;35(5):328–339.
328.
BoomarsKA, WagenaarSS, MulderPG, van Velzen BladH, van den BoschJM. Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis. Thorax1995;50(10):1087–1092.
329.
LineBR, FulmerJD, ReynoldsHY, RobertsWC, JonesAE, Har-risEK, CrystalRG. Gallium-67 citrate scanning in the staging of idio-pathic pulmonary fibrosis: Correlation and physiologic and morpho-logic features and bronchoalveolar lavage. Am Rev Respir Dis1978;118(2):355–365.
330.
Turner-WarwickM.Staging and therapy of cryptogenic fibrosing alveolitis. Chest1986;89 (3, Suppl):148S–150S.
331.
RuddRM, HaslamPL, Turner-WarwickM.Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis1981;124(1):1–8.
332.
Turner-WarwickM, HaslamPL. The value of serial bronchoalve-olar lavage in assessing the clinical progress of patients with cryp-togenic fibrosing alveolitis. Am Rev Respir Dis1987;135:26–34.
333.
GelbAF, DreisenRB, EpsteinJD, SilverthorneJD, BickelY, FieldsM, et al. Immune complexes, gallium lung scans, and bronchoalveolar lavages in idiopathic interstitial pneumonitis-fibrosis. Chest1983;84(2):148–153.
334.
MaierK, LeuschelL, CostabelU.Increased levels of oxidized methio-nine residues in bronchoalveolar lavage fluid proteins from patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis1991;143 (2):271–274.
335.
DanieleRP, HensonPM, FantoneJC, WardPA, DreisinRB. Immune complex injury of the lung. Symposium held at the 74th annual meet-ing of the American Thoracic Society, Las Vegas, Nevada, May 1979. Am Rev Respir Dis1981;124(6):738–755.
336.
HaslamPL, ThompsonB, MohammedI, TownsendPJ, HodsonME, HolborowEJ, Turner-WarwickM.Circulating immune complexes in patients with cryptogenic alveolitis. Clin Exp Immunol1979;37 (3):381–390.
337.
DreisinRB, SchwarzMI, TheofilopoulosAN, StanfordRE. Circulating immune complexes in the idiopathic interstitial pneumonia. N Engl J Med1978;298(7):353–357.
338.
Turner-WarwickM, HaslamPL, LukoszekA, TownsendP, AllanF, Du BoisRM, et al. Cells, enzymes and interstitial lung disease. The Philip Ellman Lecture. JR Coll Physicians Lond1981;15(1):5–16.
339.
MilburnHJ, GrundyJE, duBoisRM, PrenticeHG, GriffithsPD, HumoralImmune. Responses within the lung of bone marrow trans-plant recipients studied by bronchoalveolar lavage. Clin Exp Immunol1988;72(2):309–314.
340.
McCombsRP. Diseases due to immunologic reactions in the lungs. N Engl J Med1972;286(22 and 23):1186–1194 and 1245–1252.
341.
HallmanM, SpraggR, HarrellJH, MoserKM, GluckL.Evidence of lung surfactant abnormality in respiratory failure. Study of bron-choalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest1982;70(3):673–683.
342.
McCormackFX, KingTEJr, VoelkerDR, RobinsonPC, MasonRJ. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveo-lar lavage content of surfactant protein A. Am Rev Respir Dis1991;144(1):160–166.
343.
LesurOJ, ManciniNM, HumbertJC, ChabotF, PoluJM. Interleukin-6, interferon-gamma, and phospholipid levels in the alveolar lining fluid of human lungs. Profiles in coal worker's pneumoconiosis and idiopathic pulmonary fibrosis. Chest1994;106(2):407–413.
344.
RobinsonPC, WattersLC, KingTE, MasonRJ. Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids. Am Rev Respir Dis1988;137(8):585–591.
345.
GroopmanJE, GoldeDW. The histiocytic disorders: a pathophys-iologic analysis. Ann Intern Med1981;94(1):95–107.
346.
CorrinB, BussetF.A review of histiocytosis X with particular ref-erence to eosinophilic granuloma of the lung. Invest Cell Pathol1979;2(3):137–146.
347.
GraceyDR, DivertieMB, BrownALJr. Primary pulmonary histi-ocytosis x: electron microscopic study in eight cases. Chest1971;59 (1):5–9.
348.
NezelofC, BassetF, RousseauMF. Histiocytosis X histogenetic argu-ment for a Langerhans cell origin. Biomedicine1973;18(5):365–371.
349.
FriedmanPJ, LiebowAA, SokoloffJ.Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine-Bal-timore1981;60(6):385–396.
350.
LacroniqueJ, RothC, BattestiJP, BassetF, ChretienJ.Chest radi-ological features of pulmonary histiocytosis X: a report based on 50 adult cases. Thorax1982;37(2):104–109.
351.
CholletS, SolerP, DournovoP, RichardMS, FerransVJ, BassetF.Diagnosis of pulmonary histiocytosis X by immunodetection of Langer-hans cells in bronchoalveolar fluid lavage. Am J Pathol1984;115(2):225–232.
352.
UebelhoerM, BewigB, SternbergK, RabeK, NowakD, MagnussenH.BarthJ.Alveolar macrophages from bronchoalveolar lavage of patients with pulmonary histiocytosis X: determination of phenotypic and functional changes. Lung1995;173(3):187–195.
353.
AuerswaldU, BarthJ, MagnussenH.Value of CD-1-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary his-tiocytosis X. Lung1991;169(6):305–309.
354.
MurphyGF, BhanAK, SatoS, MihmMCJr, HarristTJ. A new immunologic marker for human Langerhans cells [letter]. N Engl J Med1981;304(13):791–792.
355.
KingTEJr, SchwarzMI, DreisinRE, PrattDS, TheofilopoulosAN. Circulating immune complexes in pulmonary eosinophilic granuloma. Ann Intern Med1979;91(3):397–399.
356.
BassetF, SolerP, JaurandMC, BignonJ.Ultrastructural examina-tion of broncho-alveolar lavage for diagnosis of pulmonary histio-cytosis X: preliminary report on 4 cases. Thorax1977;32(3):303–306.
357.
NagaiS.Pulmonary sarcoidosis: pathogenesis and population dif-ferences. Intern Med1995;34(9):833–838.
358.
VestboJ, ViskumK.Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis. Sarcoidosis1994;11(2):123–125.
359.
MoriPA, PesciA, BertorelliG, AnghinolfiM, StrinatiF, BarilliF, OlivieriD.The intesity of sarcoidosis alveolitis is related to albu-min and IgG levels in BAL. Respiration1988;54 (Suppl 1):30–35.
360.
DeRemeeRA. Sarcoidosis. Mayo Clin Proc1995;70(2):177–181.
361.
LineBR, HunninghakeGW, KeoghBA, JonesAE, JohnstonGS, CrystalRG. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bron-choalveolar lavage. Am Rev Respir Dis1981;123(4, Part 1):440–446.
362.
RankinJA, HuangSS, SostmanHD, GeeJB, ReynoldsHY. An anal-ysis of the inter-relationships among multiple bronchoalveolar lavage and serum determinations, physiologic tests, and clinical disease activ-ity in patients with sarcoidosis. Sarcoidosis1991;8(1):19–28.
363.
ChretienJ, VenetA, DanelC, Israel-BietD, SandronD, ArnouxA.Bronchoalveolar lavage in sarcoidosis. Respiration1985;48(3):222–230.
364.
VerstraetenA, DemedtsM, VerwilghenJ, van den EeckhoutA, MarienG, LacquetLM, CeuppensJL. Predictive value of bronchoalveolar lavage in pulmonary sarcoidosis. Chest1990;98(3):560–567.
365.
DauberJH, RossmanMD, DanieleRP. Bronchoalveolar cell pop-ulations in acute sarcoidosis. Observations in smoking and nonsmoking patients. J Lab Clin Med1979;94(6):862–871.
366.
GodardP, ClotJ, JonquetO, BousquetJ, MichelFB. Lymphocyte subpopulations in bronchoalveolar lavages of patients with sarcoidosis and hypersensitivity pneumonitis. Chest1981;80(4):447–452.
367.
GreeningAP, NunnP, DobsonN, RudolfM, ReesAD. Pulmonary sarcoidosis: alterations in bronchoalveolar lymphocytes and T cell subsets. Thorax1985;40(4):278–283.
368.
WinterbauerRH, WuR, SpringmeyerSC. Fractional analysis of the 120-ml bronchoalveolar lavage. Determination of the best specimen for diagnosis of sarcoidosis. Chest1993;104(2):344–351.
369.
CeuppensJL, LacquetLM, MarienG, DemedtsM, van den Eeck-houtA, StevensE.Alveolar T-cell subsets in pulmonary sarcoido-sis. Correlation with disease activity and effect of steroid treatment. Am Rev Respir Dis1984;129(4):563–568.
GruberR, PforteA, BeerB, RiethmullerG.Determination of gamma/delta and other T-lymphocyte subsets in bronchoalveolar lavage fluid and peripheral blood from patients with sarcoidosis and idio-pathic fibrosis of the lung. APMIS1996;104(3):199–205.
372.
HunninghakeGW, CrystalRG. Mechanism of hypergammaglob-ulinemia in pulmonary sarcoidosis. Site of increased antibody pro-duction and role of T-lymphocytes. J Clin Invest1981;67:86–92.
373.
NowakD, KanzowD, KirstenH, MagnussenH.“High intensity alve-olitis” in non-smokers and smokers with sarcoidosis. Eur Res J1991;4 (Suppl):350S.
374.
HunninghakeGW, GadekJE, YoungRCJr, KawanamiO, FerransVJ, CrystalRG. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med1980;302(11):594–598.
375.
SpiteriMA, JohnsonM, EpsteinO, SherlockS, ClarkeSW, PoulterLW. Immunological features of lung lavage cells from patients with primary biliary cirrhosis may reflect those seen in pulmonary sarcoidosis. Gut; 1990;31(2):208–212.
376.
KeoghBA, CrystalRG. Alveolitis: the key to the interstitial lung dis-orders. Thorax1982;37(1):1–10.
377.
SchoenfeldN, SchmittM, RemyN, EllensohnP, LoddenkemperR, WahnU.Activation of bronchoalveolar lavage T lymphocytes and clinical, functional and radiological features in sarcoidosis. Sarcoidosis1995;12(2):135–139.
378.
BauerW, GornyMK, BaumannHR, MorellA.T-lymphocyte sub-sets and immunoglobulin concentrations in bronchoalveolar lavage of patients with sarcoidosis and high and low intensity alveolitis. Am Rev Respir Dis1985;132(5):1060–1065.
379.
DesruesB, DelavalP, GenetetN, PencoleC, MerdrignacG, Das-sonvilleJ, et al. Does peripheral blood T-lymphocyte population dis-tribution in sarcoidosis provide a prognostic clue? Sarcoidosis1991;8(2):129–133.
380.
TukiainenP, TaskinenE, RiskaH.The prognostic value of bronchoalveolar lavage in sarcoidosis. Sarcoidosis1994;11(1):69–72.
381.
KirksDR, McCormickVD, GreenspanRH. Pulmonary sarcoidosis. Roentgenologic analysis of 150 patients. Am J Roentgenol Radium Ther Nucl Med1973;117(4):777–786.
382.
Remy-JardinM, GiraudF, RemyJ, WattinneL, WallaertB, DuhamelA.Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology1994;191(3):675–680.
383.
VeineNK, HardtF, BendixenG, RingsledJ, BrodthagenH, FaberV, et al. Immunological studies in sarcoidosis: a comparison of dis-ease activity and various immunologic parameters. Ann NY Acad Sci1979;278:47–51.
384.
SchoenbergerCI, LineBR, KeoghBA, HunninghakeGW, CrystalRG. Lung inflammation in sarcoidosis: comparison of serum angiotensin-converting enzyme levels with bronchoalveolar lavage and gallium-67 scanning assessment of the T-lymphocyte alveoli-tis. Thorax1982;37:19–25.
385.
HuangZB, EdenE.Effect of bronchoalveolar lavage fluid from patients with sarcoidosis or AIDS on interleukin I beta release from alveo-lar macrophages. Chest1990;98(3):576–580.
386.
SteffenM, PetersenJ, OldigsM, KarmeierA, MagnussenH, ThieleHG, RaedlerA.Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. J Allergy Clin Immunol1993;91(4):939–949.
387.
PueringerRJ, SchwartzDA, DaytonCS, GilbertSR, HunninghakeGW. The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease activity in sarcoidosis. Chest1993;103(3):832–838.
388.
HomolkaJ, Muller-QuernheimJ.Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis. Lung1993;171(3):173–183.
389.
StrizI, ZhengL, WangYM, PokornaH, BauerPC, CostabelU.Sol-uble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. Am J Respir Crit Care Med1995;151(2, Part 1):544–547.
390.
WaitJ, MerrillW.Presence of multinucleated giant cells in bron-choalveolar lavage fluid from sarcoid patients. Chest1982;82 (Suppl):232S.
391.
RothC, HuchonGJ, ArnouxA, Stanislas-LeguernG, MarsacJH, ChretienJ.Bronchoalveolar cells in advanced pulmonary sarcoidosis. Am Rev Respir Dis1981;124:9–12.
392.
Mordelet-DambrineMS, Stanislas-LeguernGM, HuchonGJ, Bau-mannFC, MarsacJH, ChretienJ.Elevation of the bronchoalveolar concentration of angiotensin I converting enzyme in sarcoidosis. Am Rev Respir Dis1982;126(3):472–475.
393.
AlberaC, MarbrittoI, GhioP, MarchettiL, SolidoroP, PozziE.Adeno-sine-deaminase (ADA) in bronchoalveolar fluids and serum in patients with pulmonary sarcoidosis. Eur Respir J1991;4 (Suppl):299S.
394.
BlaschkeE, EklundA, HernbrandK.Extracellular matrix compo-nents in bronchoalveolar lavage fluid in sarcoidosis and their rela-tionship to signs of alveolitis. Am Rev Respir Dis1990;141(4, Part 1):1020–1025.
395.
HallgrenR, EklundA, Engstrom-LaurentA, SchmekelB.Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflect-ing pulmonary disease. Br Med J Clin Res Ed1985;290(6484):1778–1781.
SharmaOP, FujimuraN.Hypersensitivity pneumonitis: a noninfectious granulomatosis. Semin Respir Infect1995;10(2):96–106.
401.
RobertsRC, MooreVL. Immunopathogenesis of hypersensitivity pneumonitis. Am Rev Respir Dis1977;116(6):1075–1090.
402.
SchatzM, PattersonR, FinkJ.Immunopathogenesis of hypersen-sitivity pneumonitis. J Allergy Clin Immunol1977;60(1):27–37.
403.
CaldwellJR, PearceDE, SpencerC, LederR, WaldmanRH. Immuno-logic mechanisms in hypersensitivity pneumonitis. I. Evidence for cell-mediated immunity and complement fixation in pigeons breed-ers disease. J Allergy Clin Immunol1973;52(4):225–230.
404.
YoshizawaY, MiyashitaY, InoveT, SumiY, MiyazakiY, SatoT, OhtsukaT.Sequential evaluation of clinical and immunological find-ings in hypersensitivity pneumonitis: serial subclass distribution of antibodies. Clin Immunol Immunopathol1994;73(3):330–337.
405.
RichersonHB, CoonJD, LubaroffD.Experimental hypersensitiv-ity pneumonitis in the rat: histopathology and T-cell subset com-partmentalization. Am J Respir Cell Mol Biol1991;5(5):451–463.
406.
LeathermanJW, MichaelAF, SchwartzBA, HoidalJR. Lung T cells in hypersensitivity pneumonitis. Ann Intern Med1984;100(3):390–392.
407.
CostabelU, BrossKJ, RuhleKH, LohrGW, MatthysH.la-like anti-gens on T-cells and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis. Analysis of bronchoalveolar and blood lymphocytes. Am Rev Respir Dis1985;131(3):337–342.
HunninghakeGW, KawanamiO, FerransVJ, YoungRCJr, RobertsWC, CrystalRG. Characterization of inflammatory and immune effec-tor cells in the lung parenchyma of patients with interstitial lung dis-ease. Am Rev Respir Dis1981;123(4, Part 1):407–412.
410.
BernardoJ, HunninghakeGW, GadekJE, FerransVJ, CrystalRG. Acute hypersensitivity pneumonitis: serial changes in lung lymphocyte subpopulations after exposure to antigen. Am Rev Respir Dis1979;120(5):985–994.
411.
DrentM, van Velzen BaldH, DiamantM, WagenaarSS, Hoogst-edenHC, van den BoschJM. Bronchoalveolar lavage in extrinsic allergic alveolitis: effect of time elapsed since antigen exposure. Eur Respir J1993;6:1276–1281.
412.
DrentM, van Velzen BladH, DiamantM, WagenaarSS, Donck-erwolck-BogaertM, van den BoschJM. Differential diagnosis value of plasma cells in bronchoalveolar lavage fluid. Chest1993;103(6):1720–1724.
413.
DrentM, WagenaarSS, van Velzen BladH, MulderPG, Hoogst-edenHC, van den BoschJM. Relationship between plasma cell levels and profile of bronchoalveolar lavage fluid in patients with sub-acute extrinsic allergic alveolitis. Thorax1993;48(8):835–839.
414.
TeschlerH, PohlWR, ThompsonAB, KonietzkoN, MosherDF, CostabelU, RennardSI. Elevated levels of bronchoalveolar lavage vitronectin in hypersensitivity pneumonitis. Am Rev Respir Dis1993;147(2):332–337.
415.
SilverRM. Interstitial lung disease of systemic sclerosis. Int Rev Immunol1995;12(2-4):281–291.
416.
WallaertB, HatronPY, GrosboisJM, TonnelAB, DevulderB, VoisinC.Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. Am Rev Respir Dis1986;133(4):574–580.
417.
SilverRM, MetcalfJF, StanleyJH, LeRoyEC. Interstitial lung dis-ease in scleroderma. Analysis by bronchoalveolar lavage. Arthritis Rheum1984;27:1254–1262.
418.
BehrJ, VogelmeierC, BeinertT, MeurerM, KrombachF, KonigG, FruhmannG.Bronchoalveolar lavage for evaluation and man-agement of scleroderma disease of the lung. Am J Respir Crit Care Med1996;154(2, Part 1):400–406.
419.
Peters-GoldenM, WiseRA, SchneiderP, HochbergM, StevensMB, WigleyF.Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine Baltimore1984;63(4):221–231.
420.
SilverRM, MillerKS, KinsellaMB, SmithEA, SchabelSI. Eval-uation and management of scleroderma lung disease using bron-choalveolar lavage. Am J Med1990;88(5):470–476.
421.
KonigG, LuderschmidtC, HammerC, Adelmann-GrillBC, Braun-FalcoO, FruhmannG.Lung involvement in scleroderma. Chest1984;85(3):318–324.
422.
RossiGA, BittermanPB, RennardSI, FerransVJ, CrystalRG. Evi-dence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis1985;131(4):612–617.
OhhataI, OchiT, KurebayashiS, MasutaniH, MiyagawaT, Ham-agamiS, et al. Pulmonary complications in patients with rheuma-toid arthritis. Nippon Kyobu Shikkan Gakkai Zasshi1995;33:101–108.
425.
Remy-JardinM, RemyJ, CortetB, MauriF, DelcambreB.Lung changes in rheumatoid arthritis. Radiology1994;193(2):373–382.
426.
GarciaJG, ParhamiN, KillamD, GarciaPL, KeoghBA. Bron-choalveolar lavage fluid evaluation in rheumatoid arthritis. Am Rev Respir Dis1986;133(3):450–454.
427.
GarciaJG, JamesHL, ZinkgrafS, PerlmanMB, KeoghBA. Lower respiratory tract abnormalities in rheumatoid interstitial lung disease. Potential role of neutrophils in lung injury. Am Rev Respir Dis1987;136(4):811–817.
428.
GilliganDM, O'ConnorCM, WardK, MoloneyD, BresnihanB, FitzGeraldMX. Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease. Thorax1990;45(8):591–596.
429.
FerdoutsisM, BourosD, MeletisG, PatsourakisG, SiafakasNM. Diffuse interstitial lung disease as an early manifestation of anky-losing spondylitis. Respiration1995;62(5):286–289.
430.
WendlingD, DalphinJC, TosonB, DepierreA, GuidetM.Bronchoalveolar lavage in ankylosing spondylitis. Ann Rheum Dis1990;49(5):325–326.
431.
HoffmanGS, SechlerJM, GallinJI, ShelhamerJH, SuffrediniA, OgnibeneFP, et al. Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis. Am Rev Respir Dis1991;143(2):401–407.
432.
BaltaroRJ, HoffmanGS, SechlerJM, SuffrediniAF, ShelhamerJH, FauciAS, FleisherTA. Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. Am Rev Respir Dis1991;143(2):275–278.
433.
AgustiC, XaubetA, RocaJ, AgustiAG, Rodriguez-RoisinR.Inter-stitial pulmonary fibrosis with and without associated collagen vas-cular disease: results of a two year follow up. Thorax1992;47(12):1035–1040.
434.
PrinL, CapronM, GossetP, WallaertB, KusnierzJP, BletryO, et al. Eosinophilic lung disease: immunologic studies of blood and alve-olar eosinophils. Clin Exp Immunol1986;63(1):249–257.
435.
DejaegherP, DemedtsM.Bronchoalveolar lavage in eosinophilic pneumonia before and during corticosteroid therapy. Am Rev Respir Dis1984;129(4):629–632.
AllenJN, DavisWB, PachtER. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis1990;142(3):642–647.
438.
PesciA, BertorelliG, MangenelliP, MoriPA, StrinatiF, MarangioE, et al. Bronchoalveolar lavage in chronic eosinophilic pneumonia. Analysis of six cases in comparison with other interstitial lung dis-eases. Respiration1988;54 (Suppl):16–22.
439.
OlivieriD, PesciA, BertorelliG.Eosinophilic alveolitis in immuno-logic interstitial lung disorders. Lung1990;168(Suppl):964–973.
440.
GrandordyB, HubertJ, MarsacJ, ChretienJ.Relationship between alveolar eosinophils (AE) and blood eosinophils in bronchopulmonary disease. Am Rev Respir Dis1983;127:142.
441.
Rola-PleszczynskiM, MasseS, SiroisP, LemaireI, BeginR.Early effects of low-doses exposure to asbestos on local cellular immune responses in the lung. J Immunol1981;127(6):2535–2538.
442.
BeginR, CantinA, DrapeauG, LamoureuxG, BoctorM, MasseS, Rola-PleszczynskiM.Pulmonary uptake of gallium-67 in asbestos-exposed humans and sheep. Am Rev Respir Dis1983;127(5):623–630.
443.
GellertAR, LangfordJA, WinterRJ, UthayakumarS, SinhaG, RuddRM. Asbestosis: assessment by bronchoalveolar lavage and mea-surement of pulmonary epithelial permeability. Thorax1985;40(7):508–514.
444.
WagnerJC, BerryG, SkidmoreJW, TimbrellV.The effects of the inhalation of asbestos in rats. Br J Cancer1974;29(3):252–269.
445.
GellertAR, MaceyMG, UthayakumarS, NewlandAC, RuddRM. Lymphocyte subpopulations in bronchoalveolar lavage fluid in asbestos workers. Am Rev Respir Dis1985;132(4):824–828.
446.
RoggliVL, GreenbergSD, McLartyJW, HurstGA, HiegerLR, Far-leyML, MabryLC. Comparison of sputum and lung asbestos body counts in former asbestos workers. Am Rev Respir Dis1980;122(6):941–945.
447.
NairP, RupawateRU, PrabhakaranLC, BijurS, KamatSR. Eval-uating computed tomography and broncho alveolar lavage in early diagnosis of pulmonary asbestosis. Sarcoidosis1991;8(2):115–119.
448.
KarjalainenA, AnttilaS, MantylaT, TaskinenE, KyyronenP, Tuki-ainenP.Asbestos bodies in bronchoalveolar lavage fluid in relation to occupational history. Am J Ind Med1994;26(5):645–654.
449.
SchwartzDA, GalvinJR, BurmeisterLF, MerchantRK, DaytonCS, MerchantJA, HunninghakeGW. The clinical and reliability of asbestos bodies in bronchoalveolar fluid. Am Rev Respir Dis1991;144(3, Part 1):684–688.
450.
De-VuystP.JedwabJ, DumortierP.VandermotenG, Vande-WeyerR, YarnaultJC. Asbestos bodies in bronchoalveolar lavage. Am Rev Respir Dis1982;126(6):972–976.
451.
OrlowskiE, PaironJC, AmeilleJ, JansonX, IwatsuboY, DufourG, et al. Pleural plaques, asbestos exposure, and asbestos bodies in bron-choalveolar lavage fluid. Am J Ind Med1994;26(3):349–358.
StruharD, HarbeckRJ, MansonRJ. Lymphocyte populations in lung tissue, bronchoalveolar lavage fluid, and peripheral bloods in rat at various times during the development of silicosis. Am Rev Respir Dis1989;139:28–32.
454.
BensonSC, BeltonJC, ScheveLG. Regulation of lung fibroblast pro-liferation and protein synthesis by bronchiolar lavage in experimental silicosis. Environ Res1986;41(1):61–78.
455.
LappNL, CastranovaV.How silicosis and coal workers’ pneu-moconiosis develop a cellular assessment. Occup Med1993;8(1):35–56.
456.
SaenghirunvattanaS, CharoenpanP, BoonpucknavigV, SriurairatanaS, ApibalS.Silicosis in ceramic-industry workers with particular ref-erence to the diagnostic value of bronchoalveolar lavage. J Med Assoc Thai1991;74(8):358–362.
CalhounWJ, ChristmanJW, ErshlerWB, GrahanWG, DavisGS. Raised immunoglobulin concentrations in bronchoalveolar lavage fluid of healthy granite workers. Thorax1986;41(4):266–273.
459.
BeginR, LesurO, BouhadibaT, GuojianL, LariveeP, MelloniB, et al. Phospholipid content of bronchoalveolar lavage fluid in gran-ite workers with silicosis in Quebec. Thorax1993;48(8):840–844.
460.
ClaypoolWD, RogersRM, MatuschakGM. Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar pro-teinosis (phospholipidosis). Chest1984;85(4):550–558.
461.
MahutB, DelacourC, ScheinmannP, de BlicJ, ManiTM, FournetJC, BellonG.Pulmonary alveolar proteinosis: experience with eight pediatric cases and a review. Pediatrics1996;97(1):117–122.
462.
MartinRJ, RogersRM, MyersNM. Pulmonary alveolar proteinosis: shunt fraction and lactic acid dehydrogenase concentration as aids to diagnosis. Am Rev Respir Dis1978;117(6):1059–1062.
463.
HoffmanRM, RogersRM. Serum and lavage lactate dehydrogenase isoenzymes in pulmonary alveolar proteinosis. Am Rev Respir Dis1991;143(1):42–46.
464.
HookGE, BellDY, GilmoreLB, NadeauD, ReasorMJ, TalleyFA. Composition of bronchoalveolar lavage effluents from patients with pulmonary alveolar proteinosis. Lab Invest1978;39(4):342–357.
465.
MilleronBJ, CostabelU, TeschlerH, ZiescheR, CadranelJL, MatthysH, AkounGM. Bronchoalveolar lavage cell data in alveolar proteinosis. Am Rev Respir Dis1991;144(6):1330–1332.
466.
BellDY, HookGE. Pulmonary alveolar proteinosis: analysis of air-way and alveolar proteins. Am Rev Respir Dis1979;119(6):979–990.
467.
PrakashUB, BarhamSS, CarpenterHA, DinesDE, MarshHM. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc1987;62(6):499–518.
468.
SahuS, DiAugustineRP, LynnWS. Lipids found in pulmonary lavage of patients with alveolar proteinosis and in rabbit lung lamellar organelles. Am Rev Respir Dis1976;114(1):177–185.
